Avenue Therapeutics increases authorized common shares from 75M to 200M

AVENUE THERAPEUTICS, INC.

Stockholders approved via written consent on Jan 9, 2024 to increase authorized common shares from 75M to 200M.
Certificate of Amendment filed with Delaware Secretary of State on Feb 20, 2024 effectuating the increase.
No immediate share issuance; increase provides flexibility for future capital raising or strategic transactions.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

AVENUE THERAPEUTICS, INC.: Increased authorized common stock from 75,000,000 to 200,000,000 shares (effective 2024-02-20).

Change: charter amendment
Effective: 2024-02-20

Exact text from the filing

On February 20, 2024, the Company filed a Certificate of Amendment to its Certificate of Incorporation (the “ Certificate of Amendment ”) with the Secretary of State for the State of Delaware effectuating the Authorized Shares Increase.

View on SEC.gov

Browse all governance changes →

AVENUE THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-027037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.